As of last week, cannabis growing company CANNPRISMA in Castro Marim, is officially authorised to cultivate, export and import medical cannabis. The go ahead was given after an on-site inspection by Infarmed and the Public Security Police.
Infarmed, the Portuguese government agency responsible to the Ministry of Health, evaluates, authorises, regulates and controls medicines for human use – including medical cannabis – as well as health products.
The pandemic situation delayed the process of obtaining the definitive license, but now means that the entire activity of this company complies with the Good Agricultural and Collection Practices (GACP).
The Cannprisma vision is "to be the leading Medicinal Cannabis company in the supply of premium products and solutions, innovative and competitive in the pharmaceutical industry," being the first comapny with “100% Portuguese capital to dedicate itself to the cultivation and transformation of cannabis for medicinal purposes."
The Cannprisma cultivation and processing unit, which covers 10 hectares, is located in Castro Marim and includes about 3000 square meters of greenhouses and support infrastructure with the latest technology, respecting all the required quality standards (always following all the GMP requirements) which ensures a high quality flower.
The construction of the factory in Vila Real de Santo António is not yet completed, but is expected to be up and running by the end of 2021.
There is great potential to become a leading country in research, production and to be one of the largest exporters of medicinal cannabis in Europe. The rigor, quality, safety and clarity required by Portuguese licensing entities contribute in a definitive way, so that Portugal becomes the best option for the cultivation and production of medicinal cannabis products for the whole world, but still fulfilling all requirements in terms of business ethics.
